Han-Peng Assisted Reproductive Technology Limited was founded by Dr Mingpeng Zhao, an expert of embryology at The Chinese University of Hong Kong, and brings together innovative talents from famous universities such as Nanyang Technological University, Sun Yat-sen University, and Wuhan University. It is committed to applying cutting-edge technology to reproductive medicine and improving human reproduction. The company won the Hong Kong Chinese PI-Centre, the Hong Kong Science and Technology Park STEP plan, the Hong Kong Innovation and Technology Bureau TSSSU funded and won the Shenzhen Innovation and Entrepreneurship Competition and the Qianhai Guangdong, Hong Kong, Macao and Taiwan Youth Innovation and Entrepreneurship Competition.The main research product Blastocystis® is based on the unique leading technology-morphological and dynamic segmentation-to predict embryo development, which will effectively assist doctors in making decisions about embryo transfer plans, improve embryo utilization, select better quality embryos, and ultimately increase the success rate of IVF . It has been patented in many countries and has been verified for use in Hong Kong. The company's other businesses include: Popularization of infertility treatment science, domestic/overseas clinic referral, assisted reproductive reagent supplies, animal embryo supply, assisted reproductive technology training, etc.該公司由香港中文大學胚胎學博士趙銘鵬創建，匯聚南洋理工大學、中山大學、武漢大學等名校創科人才，致力於將前沿科技應用於生殖醫學，改善人類繁衍。公司榮獲港中文PI-Centre ，香港科技園STEP計劃，香港創新科技局TSSSU資助幷在深圳市創新創業大賽，前海粵港澳臺青年創新創業大賽獲得佳績。主研產品囊胚準®基於獨有領先技術-形態動力分割-對胚胎發育進行預測，將有效輔助醫生進行胚胎移植方案決策，提高胚胎利用率，挑選更優質胚胎，幷最終提高試管嬰兒成功率。其已獲多國專利，幷在香港完成使用驗證。 公司其他業務包括： 不孕不育治療科普推廣，國內/海外診所轉介，輔助生殖試劑耗材，動物胚胎供應，輔助生殖技術培訓等業務。

2021

Biotech

TSSSU Company